MMP13 and Bartsocas-Papas syndrome 1: The changes in urinary NGF, VEGF, MMP-13, and PDGF-AB levels after intravesical PRP injections provide objective evidence of the role of PRP in alleviating inflammation, reducing abnormal angiogenesis, and improving the regeneration of defective urothelium in IC/BPS bladder.